The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Medicine-Global Market Insights and Sales Trends 2024
Synopsis
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
The global Medicine market size is expected to reach US$ 2075470 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Medicine in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Medicine market. Brand Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Generic Drug segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Medicine covered in this report include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc.
The global Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Mylan
Global Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medicine market, Segment by Type:
Brand Drugs
Generic Drug
Global Medicine market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
The global Medicine market size is expected to reach US$ 2075470 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Medicine in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Medicine market. Brand Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Generic Drug segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Medicine covered in this report include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc.
The global Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Mylan
Global Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medicine market, Segment by Type:
Brand Drugs
Generic Drug
Global Medicine market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Medicine
1.1 Medicine Market Overview
1.1.1 Medicine Product Scope
1.1.2 Medicine Market Status and Outlook
1.2 Global Medicine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Medicine Market Size by Region (2018-2029)
1.4 Global Medicine Historic Market Size by Region (2018-2023)
1.5 Global Medicine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Medicine Market Size (2018-2029)
1.6.1 North America Medicine Market Size (2018-2029)
1.6.2 Europe Medicine Market Size (2018-2029)
1.6.3 Asia-Pacific Medicine Market Size (2018-2029)
1.6.4 Latin America Medicine Market Size (2018-2029)
1.6.5 Middle East & Africa Medicine Market Size (2018-2029)
2 Medicine Market by Type
2.1 Introduction
2.1.1 Brand Drugs
2.1.2 Generic Drug
2.2 Global Medicine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Medicine Historic Market Size by Type (2018-2023)
2.2.2 Global Medicine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Medicine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Medicine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Medicine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Medicine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Medicine Revenue Breakdown by Type (2018-2029)
3 Medicine Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Other
3.2 Global Medicine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Medicine Historic Market Size by Application (2018-2023)
3.2.2 Global Medicine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Medicine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Medicine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Medicine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Medicine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Medicine Revenue Breakdown by Application (2018-2029)
4 Medicine Competition Analysis by Players
4.1 Global Medicine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medicine as of 2022)
4.3 Date of Key Players Enter into Medicine Market
4.4 Global Top Players Medicine Headquarters and Area Served
4.5 Key Players Medicine Product Solution and Service
4.6 Competitive Status
4.6.1 Medicine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Medicine Products, Services and Solutions
5.1.4 Pfizer Medicine Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Medicine Products, Services and Solutions
5.2.4 Roche Medicine Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Sanofi
5.3.1 Sanofi Profile
5.3.2 Sanofi Main Business
5.3.3 Sanofi Medicine Products, Services and Solutions
5.3.4 Sanofi Medicine Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Medicine Products, Services and Solutions
5.4.4 Johnson & Johnson Medicine Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 Merck & Co. (MSD)
5.5.1 Merck & Co. (MSD) Profile
5.5.2 Merck & Co. (MSD) Main Business
5.5.3 Merck & Co. (MSD) Medicine Products, Services and Solutions
5.5.4 Merck & Co. (MSD) Medicine Revenue (US$ Million) & (2018-2023)
5.5.5 Merck & Co. (MSD) Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Medicine Products, Services and Solutions
5.6.4 Novartis Medicine Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis Recent Developments
5.7 AbbVie
5.7.1 AbbVie Profile
5.7.2 AbbVie Main Business
5.7.3 AbbVie Medicine Products, Services and Solutions
5.7.4 AbbVie Medicine Revenue (US$ Million) & (2018-2023)
5.7.5 AbbVie Recent Developments
5.8 Gilead Sciences
5.8.1 Gilead Sciences Profile
5.8.2 Gilead Sciences Main Business
5.8.3 Gilead Sciences Medicine Products, Services and Solutions
5.8.4 Gilead Sciences Medicine Revenue (US$ Million) & (2018-2023)
5.8.5 Gilead Sciences Recent Developments
5.9 GlaxoSmithKline (GSK)
5.9.1 GlaxoSmithKline (GSK) Profile
5.9.2 GlaxoSmithKline (GSK) Main Business
5.9.3 GlaxoSmithKline (GSK) Medicine Products, Services and Solutions
5.9.4 GlaxoSmithKline (GSK) Medicine Revenue (US$ Million) & (2018-2023)
5.9.5 GlaxoSmithKline (GSK) Recent Developments
5.10 Amgen
5.10.1 Amgen Profile
5.10.2 Amgen Main Business
5.10.3 Amgen Medicine Products, Services and Solutions
5.10.4 Amgen Medicine Revenue (US$ Million) & (2018-2023)
5.10.5 Amgen Recent Developments
5.11 AstraZeneca
5.11.1 AstraZeneca Profile
5.11.2 AstraZeneca Main Business
5.11.3 AstraZeneca Medicine Products, Services and Solutions
5.11.4 AstraZeneca Medicine Revenue (US$ Million) & (2018-2023)
5.11.5 AstraZeneca Recent Developments
5.12 Bristol-Myers Squibb
5.12.1 Bristol-Myers Squibb Profile
5.12.2 Bristol-Myers Squibb Main Business
5.12.3 Bristol-Myers Squibb Medicine Products, Services and Solutions
5.12.4 Bristol-Myers Squibb Medicine Revenue (US$ Million) & (2018-2023)
5.12.5 Bristol-Myers Squibb Recent Developments
5.13 Eli Lilly
5.13.1 Eli Lilly Profile
5.13.2 Eli Lilly Main Business
5.13.3 Eli Lilly Medicine Products, Services and Solutions
5.13.4 Eli Lilly Medicine Revenue (US$ Million) & (2018-2023)
5.13.5 Eli Lilly Recent Developments
5.14 Teva
5.14.1 Teva Profile
5.14.2 Teva Main Business
5.14.3 Teva Medicine Products, Services and Solutions
5.14.4 Teva Medicine Revenue (US$ Million) & (2018-2023)
5.14.5 Teva Recent Developments
5.15 Bayer
5.15.1 Bayer Profile
5.15.2 Bayer Main Business
5.15.3 Bayer Medicine Products, Services and Solutions
5.15.4 Bayer Medicine Revenue (US$ Million) & (2018-2023)
5.15.5 Bayer Recent Developments
5.16 Novo Nordisk
5.16.1 Novo Nordisk Profile
5.16.2 Novo Nordisk Main Business
5.16.3 Novo Nordisk Medicine Products, Services and Solutions
5.16.4 Novo Nordisk Medicine Revenue (US$ Million) & (2018-2023)
5.16.5 Novo Nordisk Recent Developments
5.17 AbbVie
5.17.1 AbbVie Profile
5.17.2 AbbVie Main Business
5.17.3 AbbVie Medicine Products, Services and Solutions
5.17.4 AbbVie Medicine Revenue (US$ Million) & (2018-2023)
5.17.5 AbbVie Recent Developments
5.18 Takeda
5.18.1 Takeda Profile
5.18.2 Takeda Main Business
5.18.3 Takeda Medicine Products, Services and Solutions
5.18.4 Takeda Medicine Revenue (US$ Million) & (2018-2023)
5.18.5 Takeda Recent Developments
5.19 Boehringer Ingelheim
5.19.1 Boehringer Ingelheim Profile
5.19.2 Boehringer Ingelheim Main Business
5.19.3 Boehringer Ingelheim Medicine Products, Services and Solutions
5.19.4 Boehringer Ingelheim Medicine Revenue (US$ Million) & (2018-2023)
5.19.5 Boehringer Ingelheim Recent Developments
5.20 Mylan
5.20.1 Mylan Profile
5.20.2 Mylan Main Business
5.20.3 Mylan Medicine Products, Services and Solutions
5.20.4 Mylan Medicine Revenue (US$ Million) & (2018-2023)
5.20.5 Mylan Recent Developments
6 North America
6.1 North America Medicine Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Medicine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Medicine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Medicine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Medicine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Medicine Market Dynamics
11.1 Medicine Industry Trends
11.2 Medicine Market Drivers
11.3 Medicine Market Challenges
11.4 Medicine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
